Researchers at Queen’s have developed a highly innovative new enzyme biomarker test that has the potential to indicate diseases and bacterial contamination saving time, money and possibly lives.
The test, developed by scientists at the Institute for Global Food Security (IGFS) at Queen’s, can detect enzyme markers of disease known as proteases in humans, animals and food products.
Proteases are crucial for microorganism growth and are responsible for the progression of many diseases.
Levels of these enzyme markers can be highly elevated in the urine of patients with diabetic kidney disease, or at the sites of infected wounds. Similarly, in cows, an elevation of proteases in their milk can reveal diseases such as bovine mastitis, a type of mammary gland infection. In food, proteases produced by bacteria contaminated in meat and dairy products can lead to rancidity, as well as decreased shelf life and quality.
Current protease detection methods are costly, time-consuming and are not always effective. Scientists at the IGFS have developed a nanosensor which has resulted in sensitive, fast and cost-effective protease detection in milk and urine.
Dr Claire McVey, Queen’s researcher and co-author on the study published in leading journal Nano Research, explained: “Not only is the test cheap to produce, but it can be used anywhere and is not reliant on laboratory conditions.
“Eliminating the need to carry out tests in a laboratory setting is life-changing. As well as being cost-effective, it means faster diagnosis.”
The gold-nanoparticle based nanosensor devised by Queen’s researchers indicates when proteases are present through a visible colour-change reaction. Gold nanoparticles are well known for their capability in speeding up the oxidization of a chemical called tetramethylbenzidine (TMB), visible through a vivid blue-colour formation.
When casein (a molecule present in milk) is added to gold nanoparticles, it surrounds the nanoparticles acting as a protective surface barrier. When TMB is introduced, the casein prevents the oxidization reaction meaning there is no or only a slight colour change.
Where proteases are present, they ‘eat’ the protective casein barrier, exposing the surface of the gold nanoparticles. In this instance, when TMB is added, the proteases have removed the casein meaning oxidization occurs quickly causing a fast change in colour.
Queen’s researcher Dr Cuong Cao, a Lecturer in Advanced Micro- and Nano-Diagnostics, and the lead academic on the study: “When we add TMB to the casein-covered gold nanoparticles, we can tell virtually instantly if proteases are present by whether or not the solution turns blue. Normally such testing takes much longer.”
Using this approach, proteases can be detected within 90 minutes without the need for complicated or expensive laboratory equipment.
In addition, the ‘ingredients’ for making the nanosensor are readily available and low cost. Gold nanoparticles can be produced in abundance, with little restriction on storage requirements, making it a durable and cheap substance.
The approach developed by the Queen’s researchers was tested on milk and urine but it could be adapted for a number of other applications. Dr Cao explained: “Using molecules other than casein to coat the surface has the potential to detect other types of enzyme biomarkers. For example, coating the nanoparticles with lipids could detect the lipase enzyme, which could help in the diagnosis of diseases such as pancreatitis.
“Following full validation of this test, we would like to explore how we could expand the application to detect a host of other diseases or contaminated foods.
“This new approach will enable the identification of enzyme biomarkers at the point of care. It could change the landscape of how enzyme biomarkers are detected and diagnosed, making an impact not only on food safety, but on the diagnosis of enzyme-related illnesses among animals and humans.
“The potential scope for this test is huge.”
Professor Chris Elliott, founder of the Institute for Global Food Security and a co-investigator in the study commented: “The ability to diagnose disease or contamination quickly can have a huge impact on how serious problems can be dealt with.
“The ultra-low cost of the system will help reduce costs of testing and could transform the amount of testing performed in the developing world.”
Learn more: QUEEN’S DEVELOPS TEST TO DETECT DISEASE AND INFECTION THAT COULD SAVE TIME, MONEY AND LIVES
The Latest on: Enzyme biomarker
[google_news title=”” keyword=”enzyme biomarker” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Enzyme biomarker
- AMGEN HIGHLIGHTS NEW COPD, ASTHMA AND VASCULITIS RESEARCH AT ATS 2024on May 1, 2024 at 4:00 am
Amgen (NASDAQ:AMGN) today announced the presentation of new respiratory data at the American Thoracic Society (ATS) 2024 International Conference taking place May 12-22 in San Diego. Thirteen ...
- To save lives, the FDA must change how it evaluates rare disease treatmentson May 1, 2024 at 2:30 am
To get a green light from the FDA using the traditional approval process, new drugs must undergo two randomized, placebo-controlled clinical trials that confirm safety and clinical benefit — usually ...
- Allen J. Bard obituary: electrochemist whose techniques underpin clinical diagnostics, materials discovery and moreon April 30, 2024 at 5:00 pm
Bard’s work on electrochemiluminescence — luminescence induced by a reaction involving the transfer of electrons — led to the commercialization of sensitive assays for biomarkers in clinical ... II ...
- Enzo Biochem gets grant for method for detecting enzymes adding functional groups to compoundson April 30, 2024 at 5:43 am
Detect and quantify chemically modified compounds with Enzo Biochem Inc's patented method. Learn how to isolate compounds with functional groups for precise research and diagnostic applications.
- Opinion: Larimar Could Compete with Biogen in Friedreich’s Ataxiaon April 28, 2024 at 9:05 pm
Phase II data indicate Larimar Therapeutics’ injectable therapy nomlabofusp could go head-to-head in the market with Biogen's Skyclarys.
- APCCC 2024: PARP Inhibition Dissected – in Which DNA Repair Gene Alterations Works Which PARP Inhibitor?on April 27, 2024 at 9:50 am
Advanced Prostate Cancer Consensus Conference (APCCC) meeting featured a session on the management of metastatic castration resistant prostate cancer (mCRPC), and a presentation by Dr. Johann De Bono ...
- Health Benefits of Papayaon April 22, 2024 at 12:00 pm
Papaya (Carica papaya) contains vitamins A and C, which support your immune system and eye health. It's also high in fiber and may reduce inflammation.
- Adding ACEI to Chemotherapy Does Not Prevent Cardiotoxicityon April 18, 2024 at 3:25 am
The PROACT trial assessing enalapril in patients with cancer undergoing chemotherapy showed this approach did not affect cardiac function or the rate of cardiac injury.
- Achieve Summer-Ready Skin With These High-Performance Body Productson April 17, 2024 at 6:41 am
Get your skin ready for the summer months (and beyond) with these five must-have results-driven body products.
- Promising research for slowing Alzheimer’s disease — and moreon April 16, 2024 at 2:32 pm
Medical Watch Digest For April 16 HIV Drugs for Alzheimer’s There are no meaningful therapies to treat Alzheimer’s, the mind robbing disease which impacts nearly 7 million people in ...
via Bing News